| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3877045 | The Journal of Urology | 2007 | 4 Pages |
Abstract
Dextranomer/hyaluronic acid appears to be stable and safe for use after 3 to 22 months of followup of subureteral injection. The periureteral inflammatory reaction increases with time, although no increases in nuclear turnover or fibrosis were detected.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jonathan C. Routh, Richard A. Ashley, Thomas J. Sebo, David R. Vandersteen, Jeffrey Slezak, Yuri Reinberg,